Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kalaivani Ganapathy"'
Autor:
Sushma Kalmodia, Sowmya Parameswaran, Kalaivani Ganapathy, Wenrong Yang, Colin J. Barrow, Jagat R. Kanwar, Kislay Roy, Madavan Vasudevan, Kirti Kulkarni, Sailaja V. Elchuri, Subramanian Krishnakumar
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 9, Iss C, Pp 349-364 (2017)
Inhibition of the interaction between p53 and HDM2 is an effective therapeutic strategy in cancers that harbor a wild-type p53 protein such as retinoblastoma (RB). Nanoparticle-based delivery of therapeutic molecules has been shown to be advantageous
Externí odkaz:
https://doaj.org/article/7be3f895edc3482eb78cfafd38b5f78f
Autor:
Ravikanth Danda, Gopinath Krishnan, Kalaivani Ganapathy, Uma Maheswari Krishnan, Khetan Vikas, Sailaja Elchuri, Nivedita Chatterjee, Subramanian Krishnakumar
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83398 (2013)
In order to realise the full potential of cancer suicide gene therapy that allows the precise expression of suicide gene in cancer cells, we used a tissue specific Epithelial cell adhesion molecule (EpCAM) promoter (EGP-2) that directs transgene Herp
Externí odkaz:
https://doaj.org/article/53c0a88aabd84955a807077932b29a16
Autor:
Ravikanth Danda, Anil K. Madugundu, Uma Maheswari Krishnan, Gajanan Sathe, Akhilesh Pandey, Vikas Khetan, Pukhraj Rishi, Sailaja Elchuri, Krishnakumar Subramanian, T. S. Keshava Prasad, Kalaivani Ganapathy, Harsha Gowda
Publikováno v:
Proteomics. Clinical applications. 12(5)
Purpose Retinoblastoma (RB) is a pediatric ocular cancer which is caused due to the aberrations in the RB1 gene. The changes in the membrane proteomics would help in understanding the development of the retinoblastoma and could identify candidates fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d381261c434aa8ce168e8e59e6b1563
https://pubmed.ncbi.nlm.nih.gov/29742327
https://pubmed.ncbi.nlm.nih.gov/29742327
Autor:
Ravikanth Danda, Gajanan Sathe, Pukhraj Rishi, Subramanian Krishnakumar, Vikas Khetan, Sharavan Ramachandran, Kalaivani Ganapathy, Sailaja Elchuri, Akhilesh Pandey, T. S. Keshava Prasad, Harsha Gowda, Anil K. Madugundu, Uma Maheswari Krishnan
Publikováno v:
Clinical Proteomics
Background Retinoblastoma is an ocular neoplastic cancer caused primarily due to the mutation/deletion of RB1 gene. Due to the rarity of the disease very limited information is available on molecular changes in primary retinoblastoma. High throughput
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8bb1ed59e4862658512bdc79897efd0
https://doi.org/10.1186/s12014-016-9128-7
https://doi.org/10.1186/s12014-016-9128-7
Autor:
Ravikanth Danda, Kalaivani Ganapathy, Gajanan Sathe, Madugundu, Anil, Sharavan Ramachandran, Krishnan, Uma, Khetan, Vikas, Pukhraj Rishi, T. Keshava Prasad, Akhilesh Pandey, Krishnakumar, Subramanian, Harsha Gowda, Sailaja Elchuri
Additional file 1: Table S1. The clinicopathological features of the RB tumors from patients used in the study for the protein extraction and proteoomic analysis described in detail in the methods section. Table S2. The clinicopathological features o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00594eaf901ecd4206f3b810dd4a4a6
